{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:42:14Z","timestamp":1793356934954,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s11604-026-02058-7","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:05:32Z","timestamp":1786687532000},"page":"2029-2040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of lesion detection rates between FAPI PET\/CT and 18F-FDG PET\/CT in hepatocellular carcinoma: a systematic review and meta-analysis of head-to-head studies"],"prefix":"10.1007","volume":"44","author":[{"given":"Qin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1072-7236","authenticated-orcid":false,"given":"Yuqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"2","key":"2058_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000518837","volume":"11","author":"HI Kim","year":"2022","unstructured":"Kim HI, An J, Kim JY, et al. Postresection period-specific hazard of recurrence as a framework for surveillance strategy in patients with hepatocellular carcinoma: a multicenter outcome study. Liver Cancer. 2022;11(2):141\u201351. https:\/\/doi.org\/10.1159\/000518837.","journal-title":"Liver Cancer"},{"key":"2058_CR2","doi-asserted-by":"publisher","unstructured":"Li Y, Hu PC, Liu GB. Factors affecting liver uptake of 18F-FDG on PET\/CT imaging. 2015;35:506\u2013508. https:\/\/doi.org\/10.3760\/cma.j.issn.2095-2848.2015.06.022","DOI":"10.3760\/cma.j.issn.2095-2848.2015.06.022"},{"issue":"2","key":"2058_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","volume":"62","author":"A Altmann","year":"2021","unstructured":"Altmann A, Haberkorn U, Siveke J. The latest developments in imaging of fibroblast activation protein. J Nucl Med. 2021;62(2):160\u20137. https:\/\/doi.org\/10.2967\/jnumed.120.244806.","journal-title":"J Nucl Med"},{"key":"2058_CR4","doi-asserted-by":"publisher","unstructured":"Hernandez-Hidalgo N, Cortes G, Ortega-Anaya K, et al. Fibroblast activation protein inhibitors positron emission tomography\/computed tomography: Review of the literature. World J Metaanal. 2024;12(4). https:\/\/doi.org\/10.13105\/wjma.v12.i4.95755","DOI":"10.13105\/wjma.v12.i4.95755"},{"issue":"2","key":"2058_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.62347\/TUZI7617","volume":"15","author":"T Zhao","year":"2025","unstructured":"Zhao T, Liang SH. Multivalent FAPI-based radiopharmaceuticals in PET\/CT: from cancer diagnostics to theranostics. Am J Nucl Med Mol Imaging. 2025;15(2):82\u20136. https:\/\/doi.org\/10.62347\/TUZI7617.","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"1","key":"2058_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-023-00626-y","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jiang S, Li M, et al. Head-to-head comparison of 18F-FAPI and 18F-FDG PET\/CT in staging and therapeutic management of hepatocellular carcinoma. Cancer Imaging. 2023;23(1):106. https:\/\/doi.org\/10.1186\/s40644-023-00626-y.","journal-title":"Cancer Imaging"},{"issue":"3","key":"2058_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s00259-025-07548-w","volume":"53","author":"H Gong","year":"2026","unstructured":"Gong H, Cheng Y, Li Q, et al. The diagnostic value of 18F-FAPI-04 PET\/CT in unresectable hepatocellular carcinoma: a head-to-head comparison with 18F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2026;53(3):1700\u201318. https:\/\/doi.org\/10.1007\/s00259-025-07548-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2058_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693640","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Zhu W, Ren S, et al. 18Ga-FAPI-04 Versus 18F-FDG PET\/CT in the detection of hepatocellular carcinoma. Front Oncol. 2021;11:693640. https:\/\/doi.org\/10.3389\/fonc.2021.693640.","journal-title":"Front Oncol"},{"issue":"5","key":"2058_CR9","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","volume":"48","author":"W Guo","year":"2021","unstructured":"Guo W, Pang Y, Yao L, et al. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [18Ga]Ga-FAPI-04 PET\/CT versus MRI and [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48(5):1604\u201317. https:\/\/doi.org\/10.1007\/s00259-020-05095-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2058_CR10","doi-asserted-by":"publisher","unstructured":"Xu W, Meng T, Pang Y, et al. Al18F-NOTA-FAPI PET\/CT in the evaluation of gastric, liver, and pancreatic cancer and comparison with 18F-FDG PET\/CT. J Nucl Med. 2023;64(Suppl 1). https:\/\/doi.org\/10.2967\/jnumed.123.266329","DOI":"10.2967\/jnumed.123.266329"},{"issue":"6","key":"2058_CR11","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s00259-024-07062-5","volume":"52","author":"D Zhu","year":"2025","unstructured":"Zhu D, Song S, Zou S, et al. Assessment of viable tumours by [18Ga]Ga-FAPI-04 PET\/CT after local regional treatment in patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2025;52(6):2132\u201344. https:\/\/doi.org\/10.1007\/s00259-024-07062-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2058_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.4103\/jcrt.jcrt_1144_25","volume":"21","author":"H Wang","year":"2025","unstructured":"Wang H, Wang J, Li G. Comparative diagnostic efficacy of 18F-FDG and FAPI PET\/CT in primary liver cancers: a systematic review and meta-analysis. J Cancer Res Ther. 2025;21(6):1227\u201335. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1144_25.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"2058_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00261-024-04302-y","volume":"50","author":"A Mohebbi","year":"2025","unstructured":"Mohebbi A, Kiani I, Mohammadzadeh S, et al. Qualitative and quantitative differentiation efficiency of dual-tracer PET\/CT with 18F-fluorodeoxyglucose and 11C-acetate for primary hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol. 2025;50(1):198\u2013212. https:\/\/doi.org\/10.1007\/s00261-024-04302-y.","journal-title":"Abdom Radiol"},{"issue":"9","key":"2058_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/RLU.0b013e3182a75812","volume":"39","author":"A Dong","year":"2014","unstructured":"Dong A, Yu H, Wang Y, et al. FDG PET\/CT and enhanced CT imaging of tumor heterogeneity in hepatocellular carcinoma: imaging-pathologic correlation. Clin Nucl Med. 2014;39(9):808\u201310. https:\/\/doi.org\/10.1097\/RLU.0b013e3182a75812.","journal-title":"Clin Nucl Med"},{"key":"2058_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16020249","author":"Z Zholdybay","year":"2026","unstructured":"Zholdybay Z, Zhakenova Z, Issamatov B, et al. 18Ga-FAPI-04 PET\/CT in the diagnosis of hepatocellular carcinoma associated with cirrhosis: diagnostic value, correlation between PET parameters of the tumor and its size, and PIVKA-II levels. Diagnostics. 2026. https:\/\/doi.org\/10.3390\/diagnostics16020249.","journal-title":"Diagnostics"},{"issue":"10","key":"2058_CR16","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1097\/RLU.0000000000003015","volume":"45","author":"L Zhao","year":"2020","unstructured":"Zhao L, Gu J, Fu K, et al. 18Ga-FAPI PET\/CT in Assessment of liver nodules in a cirrhotic patient. Clin Nucl Med. 2020;45(10):e430\u20132. https:\/\/doi.org\/10.1097\/RLU.0000000000003015.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2058_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3881\/j.issn.1000-503X.15221","volume":"45","author":"AB Wang","year":"2023","unstructured":"Wang AB, Feng LJ, Ni PP, et al. Causes of False-Positive Results in 18Ga-Labeled Fibroblast Activation Protein Inhibitor PET\/CT Imaging. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023;45(3):440\u20134. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.15221.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"11","key":"2058_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/RLU.0000000000005342","volume":"49","author":"J Ding","year":"2024","unstructured":"Ding J, Zhao J, Chen X, et al. The added value of contrast-enhanced 18Ga-FAPI-04 PET\/MRI over 18F-FDG PET\/CT in hepatocellular carcinoma. Clin Nucl Med. 2024;49(11):1039\u201340. https:\/\/doi.org\/10.1097\/RLU.0000000000005342.","journal-title":"Clin Nucl Med"},{"issue":"18","key":"2058_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.13748\/j.cnki.issn1007-7693.20251183","volume":"42","author":"N Wu","year":"2025","unstructured":"Wu N, Li Q, Chen L, Wang Q, Ge Y, Yu C, et al. Comparison of application of radiopharmaceutical 18F-FAPI and 18F-FDG in PET\/CT imaging of hepatic malignancies. Zhongguo Xiandai Yingyao Yaoxue. 2025;42(18):16\u201323. https:\/\/doi.org\/10.13748\/j.cnki.issn1007-7693.20251183.","journal-title":"Zhongguo Xiandai Yingyao Yaoxue"},{"issue":"8","key":"2058_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MNM.0000000000001994","volume":"46","author":"QC Wan","year":"2025","unstructured":"Wan QC, Cheng MH, Xie LJ. Semiquantitative analysis of 18F-aluminum fluoride fibroblast activation protein inhibitor 42 PET\/computed tomography in primary liver cancer and factors influencing imaging positivity rates. Nucl Med Commun. 2025;46(8):753\u20139. https:\/\/doi.org\/10.1097\/MNM.0000000000001994.","journal-title":"Nucl Med Commun"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02058-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02058-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02058-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:15:26Z","timestamp":1793355326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02058-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02058-7","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}